| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 10/02/2007 | US7276145 PH electrode |
| 10/02/2007 | US7276141 Hydrogen gas sensor |
| 10/02/2007 | US7276029 System and methods for processing analyte sensor data |
| 10/02/2007 | US7275858 Retaining microfluidic microcavity and other microfluidic structures |
| 10/02/2007 | US7275423 Automatic speed calculation for scratch machine |
| 10/02/2007 | US7275420 Fluid sensor fixture for dynamic fluid testing |
| 10/02/2007 | US7275418 Method for the quantitative detection of two contaminants in a fluid |
| 10/02/2007 | CA2419046C Method for detecting or measuring hbv |
| 10/02/2007 | CA2408616C Microfluidic channel embryo and/or oocyte handling, analysis and biological evaluation |
| 10/02/2007 | CA2262018C Nanoparticles having oligonucleotides attached thereto and uses therefor |
| 10/02/2007 | CA1341552C Method of producing human-human hybridomas, the production of monoclonal and polyclonal antibodies therefrom, and therapeutic use thereof |
| 09/30/2007 | CA2748433A1 Systems and methods of discriminating control solution from a physiological sample |
| 09/30/2007 | CA2582236A1 Tumor models employing green fluorescent protein |
| 09/28/2007 | CA2541522A1 A double elisa for alzheimer's disease (ad) with applications for therapeutic vaccines to stop the disease |
| 09/27/2007 | WO2007109809A1 Methods and reagents for in vivo imaging of cancer cell lines |
| 09/27/2007 | WO2007109733A2 Diagnostic and prognostic markers and treatment strategies for multiple sclerosis |
| 09/27/2007 | WO2007109690A2 Authenticating and identifying objects by detecting markings through turbid materials |
| 09/27/2007 | WO2007109598A2 Hydrogen sulfide generator for sensor calibration |
| 09/27/2007 | WO2007109527A1 Methods of identifying and treating individuals exhibiting mutant bcr/abl kinase polypeptides |
| 09/27/2007 | WO2007109500A1 Lateral flow devices |
| 09/27/2007 | WO2007109465A2 Lanthanide complexes as fluorescent indicators for neutral sugars and cancer diagnosis |
| 09/27/2007 | WO2007109396A2 Reference control composition containing a nucleated red blood cell component made of non-nucleated blood cells |
| 09/27/2007 | WO2007109370A2 Methods for identifying polypeptide targets and uses thereof for treating immunological diseases |
| 09/27/2007 | WO2007109321A2 Engineered anti-prostate stem cell antigen (psca) antibodies for cancer targeting |
| 09/27/2007 | WO2007109293A2 Early diagnosis of congenital abnormalities in the offspring of diabetic mothers |
| 09/27/2007 | WO2007109243A2 Methods for comparing the immunogenicity of products and uses thereof |
| 09/27/2007 | WO2007109155A2 Assays for detection of antibodies to lysosomal enzymes |
| 09/27/2007 | WO2007109102A2 Methods for interventions and testing for caloric restriction (cr) mimetics |
| 09/27/2007 | WO2007109056A2 Use of gelsolin to diagnose and treat inflammatory diseases |
| 09/27/2007 | WO2007108954A2 Method for monitoring feeds to catalytic cracking units by near-infrared spectroscopy |
| 09/27/2007 | WO2007108900A1 Method and apparatus for coding diagnostic meters |
| 09/27/2007 | WO2007108835A2 Automatable artificial immune system (ais) |
| 09/27/2007 | WO2007108829A2 Tuberculosis nucleic acids, polypeptides and immunogenic compositions |
| 09/27/2007 | WO2007108779A1 Microfluidic device for analyzing the status of a particle |
| 09/27/2007 | WO2007108773A1 Device for analyzing the status of a particle |
| 09/27/2007 | WO2007108756A1 Improved protofibril selective antibodies and the use thereof |
| 09/27/2007 | WO2007108755A1 Plex method |
| 09/27/2007 | WO2007108710A1 A method of manufacturing a test for the detection of narcotics, particularly gamma- hydroxybutiric acid (ghb), and a method of detecting their presence |
| 09/27/2007 | WO2007108675A1 Methods of binding of cross-beta structures by chaperones |
| 09/27/2007 | WO2007108557A1 Control of intracellular target molecule by ip3 receptor-binding protein |
| 09/27/2007 | WO2007108523A1 Method of evaluating skin sensitivity level by using squamous cell carcinoma-related antigen as indication |
| 09/27/2007 | WO2007108368A1 Panel cell used for granulocyte antibody detection |
| 09/27/2007 | WO2007108214A1 Analyzing element and analyzing apparatus using same |
| 09/27/2007 | WO2007108204A1 Method of preparing analysis sample, analysis sample and sugar chain capture agent |
| 09/27/2007 | WO2007108173A1 Biomolecular element, multilayer molecular thin film of fatty acid and lipid to be support for biosensor molecule and method for producing the same |
| 09/27/2007 | WO2007108005A1 Chimeric tymovirus-like particles |
| 09/27/2007 | WO2007107892A1 Microelectronic sensor device with sensor array |
| 09/27/2007 | WO2007107858A1 Magnetic immunochromatographic test method and device |
| 09/27/2007 | WO2007107849A1 Apparatus for the determination of ethanol content in liquid or aeriform substances and corresponding process |
| 09/27/2007 | WO2007107774A2 Integrin alpha-10 subunit as therapeutic target and diagnostic/prognostic marker for cancer |
| 09/27/2007 | WO2007107743A1 Method for analyte detection using proximity probes |
| 09/27/2007 | WO2007107716A1 A chemical sensing device |
| 09/27/2007 | WO2007107714A2 Clinical correlates |
| 09/27/2007 | WO2007107636A1 Apparatuses and method for studying material properties |
| 09/27/2007 | WO2007107370A1 Cytokine-based pyrogen test |
| 09/27/2007 | WO2007107334A1 Ex vivo cancer diagnostic method |
| 09/27/2007 | WO2007107320A1 Method for determining the therapeutic effectiveness of substances |
| 09/27/2007 | WO2007107165A1 Method for identifying compounds for the treatment of depression |
| 09/27/2007 | WO2007107151A2 Diagnostic test system for the simultaneous, quantitative detection of hiv1 and hiv2 antibodies and/or hiv antigens in human sample material |
| 09/27/2007 | WO2007107003A1 Markers for the diagnosis, monitoring and prognosis of osteoporosis and for assessing the risk for osteoporosis and for osteoporotic fractures |
| 09/27/2007 | WO2007107002A1 Markers for the diagnosis, monitoring and prognosis of osteoporosis and for assessing the risk for osteoporosis and for osteoporotic fractures |
| 09/27/2007 | WO2007106991A1 Identification of crmp4 as a convergent regulator of axon outgrowth inhibition |
| 09/27/2007 | WO2007106942A1 Analysis of grape quality using neural network |
| 09/27/2007 | WO2007106939A1 A method for detecting antigen-specific or mitogen-activated t cells |
| 09/27/2007 | WO2007106936A1 Electrochemical sensor |
| 09/27/2007 | WO2007106917A1 Device for monitoring microbiological water quality |
| 09/27/2007 | WO2007093449A3 Method and means for high- throughput -screening of compounds that exhibit anti -arenavirus activity |
| 09/27/2007 | WO2007092864A9 Calibration arrangement for breath testing equipment |
| 09/27/2007 | WO2007089691A9 Computer-implemented land planning system and method |
| 09/27/2007 | WO2007088349A3 Use of anti-vimentin antibodies in diagnosis of hypertension or heart failure |
| 09/27/2007 | WO2007087403A3 Self-calibrating gas detector and method |
| 09/27/2007 | WO2007082181A3 Methods of modulating cell surface receptors to prevent or reduce inflammation |
| 09/27/2007 | WO2007081790A3 Methods for diagnosing and treating prostate cancer |
| 09/27/2007 | WO2007081635A3 Method and apparatus for analyzing arsenic concentrations using gas phase ozone chemiluminescence |
| 09/27/2007 | WO2007080622A3 Luminescent stem cells and uses thereof |
| 09/27/2007 | WO2007075922A3 Portable sample analyzer cartridge |
| 09/27/2007 | WO2007065116A3 Method for detection of antigens |
| 09/27/2007 | WO2007061656A3 Method for detecting ovarian cancer |
| 09/27/2007 | WO2007057744A3 Fluid reservoir |
| 09/27/2007 | WO2007055388A3 Calcium receptor activator |
| 09/27/2007 | WO2007054850A3 Device for testing a fluid |
| 09/27/2007 | WO2007050531A3 Diagnostic application of mail |
| 09/27/2007 | WO2007035917A3 Methods of determination of responsiveness to erythroproietin treatment |
| 09/27/2007 | WO2007025129A3 Compositions and liquid crystals |
| 09/27/2007 | WO2007022436A3 Hematopoietic cell phenotyping using circulating cell-free markers |
| 09/27/2007 | WO2007019273A3 Phosphorylation of tau by abl |
| 09/27/2007 | WO2006127675A3 Nanoparticles and method to control nanoparticle spacing |
| 09/27/2007 | WO2006089185A8 Pharmacogenomic markers for prognosis of solid tumors |
| 09/27/2007 | WO2006073782A9 Colorimetric sensors constructed of diacetylene materials |
| 09/27/2007 | WO2006073504A8 Wobble sequencing |
| 09/27/2007 | WO2006066064A3 A voltage-gated, ph-sensitive anion channel and its novel splice variant involved in taste sensation |
| 09/27/2007 | WO2005086760A3 Monitoring and maintaining equipment and machinery |
| 09/27/2007 | WO2005046583A3 Modified fviii having reduced immunogenicity through mutagenesis of a2 and c2 epitopes |
| 09/27/2007 | WO2003078662A9 Gene expression profiling in biopsied tumor tissues |
| 09/27/2007 | US20070226813 Methods of screening for antitumor agents |
| 09/27/2007 | US20070225488 Magnetic particles and methods of producing coated magnetic particles |
| 09/27/2007 | US20070225485 Foldable polymers as probes |
| 09/27/2007 | US20070225482 immobilization with control over the orientation of the attachment; efficient, not requiring the previous purification of the protein to be attached, and can be activated by UV-light; photolithography |
| 09/27/2007 | US20070225242 Method and composition for treating and preventing tumor metastasis in vivo |
| 09/27/2007 | US20070225240 Screening Assay and Treatment |